Prospective Longitudinal Cohort Study of Implant Age, Pocket Plane, Incision, Surface Texture, and Volume as Predictors of Clinically Significant Capsular Contracture

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorResearch Inc

About this trial

This prospective breast implant surveillance cohort will evaluate whether implant age, pocket plane, incision route, surface texture, and volume predict clinically significant capsular contracture. Women with Baker grade I or II aesthetic implants at enrollment will undergo standardized annual assessments for up to five years. The primary outcome is time to incident Baker grade III or IV contracture. Progression, pain, imaging, treatment, and patient-reported outcomes will also be described.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Female sex and age 18 years or older.

Aesthetic breast augmentation with permanent silicone or saline implants under the final protocol.

Baker grade I or II in the analyzed breast at cohort entry, confirmed by standardized examination.

Known implantation date or year and known pocket plane, incision route, surface texture, and volume.

Disqualifiers

Baker grade III or IV contracture at cohort entry in the analyzed breast.

Reconstructive implantation after mastectomy or major trauma.

Tissue expander.

Active breast infection or open wound at enrollment.

Trial population

Adult women with aesthetic breast implants and no clinically significant capsular contracture at cohort entry.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Breast Implant Exposure

    Device

    Implant-level data include age, laterality, material, surface texture, shape, volume, pocket plane, incision route, primary or revision placement, manufacturer/lot when available, and concomitant mastopexy or fat grafting. Linked arm/group(s): Breast Implant Capsule Surveillance Cohort.

  • Standardized Capsular Contracture Assessment

    Diagnostic test

    Two trained assessors will apply a standardized Baker grading protocol, with breast firmness, distortion, pain, and imaging recorded. Suspected grade III/IV events will undergo central review or operative confirmation when surgery occurs. Linked arm/group(s): Breast Implant Capsule Surveillance Cohort.

Treatment groups

3,000 Participants
are divided into 1 treatment group
Group A: Breast Implant Capsule Surveillance Cohort2 interventions

Trial outcomes

Primary outcomes

1

Time to Incident Baker Grade III or IV Capsular Contracture

Implant-level time from cohort entry to the first confirmed clinically significant contracture. Grade III is visible distortion/firmness and grade IV includes pain under the locked examination manual. Bilateral implants will be clustered by participant.

Time frame
From cohort entry through years of prospective follow-up. 10 years

Secondary outcomes

1

Capsular Contracture-Free Survival by Implant Age

Probability of remaining free of Baker grade III/IV contracture at prespecified implant ages, estimated with delayed-entry survival methods when prevalent implants are included.

Time frame
Prospective follow-up through 10 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.